loadpatents
name:-0.042023181915283
name:-0.019043922424316
name:-0.071979999542236
Platenburg; Gerard Johannes Patent Filings

Platenburg; Gerard Johannes

Patent Applications and Registrations

Patent applications and USPTO patent grants for Platenburg; Gerard Johannes.The latest application filed is for "treatment of genetic disorders associated with dna repeat instability".

Company Profile
10.18.34
  • Platenburg; Gerard Johannes - Voorschoten NL
  • PLATENBURG; Gerard Johannes - Vorschoten NL
  • Platenburg; Gerard Johannes - Leiden NL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA
Grant 11,427,820 - De Kimpe , et al. August 30, 2
2022-08-30
Treatment Of Genetic Disorders Associated With Dna Repeat Instability
App 20220267765 - DE KIMPE; Josephus Johannes ;   et al.
2022-08-25
Methods and means for treating DNA repeat instability associated genetic disorders
Grant 11,274,299 - De Kimpe , et al. March 15, 2
2022-03-15
Oligonucleotide Comprising An Inosine For Treating Dmd
App 20210254071 - van Deutekom; Judith Christina Theodora ;   et al.
2021-08-19
Method For Efficient Exon (44) Skipping In Duchenne Muscular Dystrophy And Associated Means
App 20210207138 - Platenburg; Gerard Johannes ;   et al.
2021-07-08
Oligonucleotide comprising an inosine for treating DMD
Grant 11,034,956 - Van Deutekom , et al. June 15, 2
2021-06-15
Means and methods for counteracting muscle disorders
Grant RE48,468 - De Kimpe , et al. March 16, 2
2021-03-16
Oligonucleotide Comprising An Inosine For Treating Dmd
App 20200291399 - Van Deutekom; Judith Christina Theodora ;   et al.
2020-09-17
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20200239886 - De Kimpe; Josephus Johannes ;   et al.
2020-07-30
Treatment of genetic disorders associated with DNA repeat instability
Grant 10,689,646 - De Kimpe , et al.
2020-06-23
Methods and means for treating DNA repeat instability associated genetic disorders
App 20200140857 - DE KIMPE; Josephus Johannes ;   et al.
2020-05-07
Oligonucleotide comprising an inosine for treating DMD
Grant 10,533,171 - Van Deutekom , et al. Ja
2020-01-14
Method For Efficient Exon (44) Skipping In Duchenne Muscular Dystrophy And Associated Means
App 20190292541 - Platenburg; Gerard Johannes ;   et al.
2019-09-26
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20190177725 - De Kimpe; Josephus Johannes ;   et al.
2019-06-13
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20190119679 - De Kimpe; Josephus Johannes ;   et al.
2019-04-25
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20190112604 - De Kimpe; Josephus Johannes ;   et al.
2019-04-18
Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
Grant 10,246,707 - Platenburg , et al.
2019-04-02
Treatment Of Genetic Disorders Associated With DNA Repeat Instability
App 20180112214 - De KIMPE; Josephus Johannes ;   et al.
2018-04-26
Treatment of genetic disorders associated with DNA repeat instability
Grant 9,890,379 - De Kimpe , et al. February 13, 2
2018-02-13
Oligonucleotide Comprising An Inosine For Treating Dmd
App 20170204414 - Van DEUTEKOM; Judith Christina Theodora ;   et al.
2017-07-20
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20170107512 - De KIMPE; Josephus Johannes ;   et al.
2017-04-20
Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA
Grant 9,528,109 - De Kimpe , et al. December 27, 2
2016-12-27
Means And Methods For Counteracting Muscle Disorders
App 20160304864 - De KIMPE; Josephus Johannes ;   et al.
2016-10-20
Oligonucleotide Comprising An Inosine For Treating Dmd
App 20160264967 - Van DEUTEKOM; Judith Christina Theodora ;   et al.
2016-09-15
Method For Efficient Exon (44) Skipping In Duchenne Muscular Dystrophy And Associated Means
App 20160053262 - Platenburg; Gerard Johannes ;   et al.
2016-02-25
Treatment Of Genetic Disorders Associated With Dna Repeat Instability
App 20160053254 - De KIMPE; Josephus Johannes ;   et al.
2016-02-25
Means and methods for counteracting muscle disorders
Grant 9,243,245 - De Kimpe , et al. January 26, 2
2016-01-26
Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
Grant 9,139,828 - Platenburg , et al. September 22, 2
2015-09-22
Oligonucleotide comprising an inosine for treating DMD
App 20150203849 - van Deutekom; Judith Christina Theodora ;   et al.
2015-07-23
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20150073037 - De Kimpe; Josephus Johannes ;   et al.
2015-03-12
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20140221458 - De Kimpe; Josephus Johannes ;   et al.
2014-08-07
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20140128592 - De Kimpe; Josephus Johannes ;   et al.
2014-05-08
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20140113955 - De Kimpe; Josephus Johannes ;   et al.
2014-04-24
Molecules for targeting compounds to various selected organs, tissues or tumor cells
Grant 8,609,065 - Kuik-Romeijn , et al. December 17, 2
2013-12-17
Molecules for targeting compounds to various selected organs or tissues
Grant 8,519,097 - Heemskerk , et al. August 27, 2
2013-08-27
Molecules For Targeting Compounds To Various Selected Organs Or Tissues
App 20120322724 - Heemskerk; Johannes Antonius ;   et al.
2012-12-20
Molecules for targeting compounds to various selected organs or tissues
Grant 8,268,962 - Heemskerk , et al. September 18, 2
2012-09-18
Mannose-6-phosphate receptor mediated gene transfer into muscle cells
App 20120122801 - PLATENBURG; Gerard Johannes
2012-05-17
Method For Efficient Exon (44) Skipping In Duchenne Muscular Dystrophy And Associated Means
App 20120059042 - Platenburg; Gerard Johannes ;   et al.
2012-03-08
Means and methods for counteracting muscle disorders
App 20110294753 - De Kimpe; Josephus Johannes ;   et al.
2011-12-01
NOVEL mRNA SPLICE VARIANT OF THE DOUBLECORTIN-LIKE KINASE GENE AND ITS USE IN DIAGNOSIS AND THERAPY OF CANCERS OF NEUROECTODERMAL ORIGIN
App 20110229552 - Vreugdenhil; Erno ;   et al.
2011-09-22
Mannose-6-phosphate receptor mediated gene transfer into muscle cells
App 20110110960 - PLATENBURG; Gerard Johannes
2011-05-12
Molecules For Targeting Compounds To Various Selected Organs, Tissues Or Tumor Cells
App 20100184947 - Kuik-Romeijn; Petra Van ;   et al.
2010-07-22
Molecules For Targeting Compounds To Various Selected Organs Or Tissues
App 20100184948 - HEEMSKERK; JOHANNES ANTONIUS ;   et al.
2010-07-22
Methods And Means For Treating Dna Repeat Instability Associated Genetic Disorders
App 20100184833 - De Kimpe; Josephus Johannes ;   et al.
2010-07-22
Antibiotic Composition
App 20090318403 - De Visser; Peter Christian ;   et al.
2009-12-24
Compounds for Hydrolyzing Ribonucleic Acids (RNA's)
App 20090233981 - Wanner; Brigitte ;   et al.
2009-09-17
Mannose-6-phosphate receptor mediated gene transfer into muscle cells
App 20060148740 - Platenburg; Gerard Johannes
2006-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed